Loading clinical trials...
Loading clinical trials...
This is a multi-center, double-blind, randomized, Phase 2b trial to evaluate the efficacy of atacicept in subjects with systemic lupus erythematosus (SLE).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
EMD Serono
NCT07330245 · Lupus Erythematosus, Systemic
NCT07015983 · Lupus Erythematosus, Systemic, Lupus Nephritis
NCT07438496 · Lupus Erythematosus, Systemic
NCT06673043 · Lupus Erythematosus, Systemic
NCT05648500 · Lupus Erythematosus, Systemic
Pinnacle Research Group LLC
Anniston, Alabama
Achieve Clinical Research, LLC
Birmingham, Alabama
University of Alabama at Birmingham - (UAB)
Birmingham, Alabama
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions